Compounds > tris(2-carboxyethyl)phosphine
Page last updated: 2024-09-03

tris(2-carboxyethyl)phosphine and Obesity

tris(2-carboxyethyl)phosphine has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chen, X; Gu, N; Oh, Y; Wei, X; Yang, D; Zhang, Z; Zhu, R1
Chen, X; Du, H; Fan, X; Gu, N; Hu, H; Oh, Y; Wei, X; Yang, D; Zhang, B; Zhang, Z; Zhao, M; Zhu, R1

Other Studies

2 other study(ies) available for tris(2-carboxyethyl)phosphine and Obesity

ArticleYear
Tris (2-chloroethyl) phosphate (TCEP) induces obesity and hepatic steatosis via FXR-mediated lipid accumulation in mice: Long-term exposure as a potential risk for metabolic diseases.
    Chemico-biological interactions, 2022, Aug-25, Volume: 363

    Topics: Animals; Bile Acids and Salts; Fatty Liver; Flame Retardants; Humans; Lipids; Metabolic Diseases; Mice; Mice, Inbred ICR; Obesity; Organophosphates; Phosphates; Phosphines

2022
Probiotics protect against hepatic steatosis in tris (2-chloroethyl) phosphate-induced metabolic disorder of mice via FXR signaling.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2022, Volume: 169

    Topics: Animals; Flame Retardants; Lipids; Metabolic Diseases; Mice; Obesity; Organophosphates; Phosphates; Phosphines; PPAR alpha; PPAR gamma; Probiotics; Signal Transduction

2022